|
1 |
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience
Enthalten in Breast care Bd. 20, 2025, Nr. 2: 57-65. 8 S.
|
|
|
|
2 |
Antibody–drug conjugates in ovarian cancer
Enthalten in Magazine of European Medical Oncology 25.1.2024: 1-5
|
|
|
3 |
Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness
Kuehne, Felicitas. - Hannover : Hochschule Hannover, 2022
|
|
|
|
4 |
Maintenance therapy with aromatase inhibitor in epithelial ovarian cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial
McLaughlin, Pamela M. J.. - Freiburg : Universität, 2022
|
|
|
|
5 |
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Enthalten in Wiener klinische Wochenschrift 10.2.2022: 1-4
|
|
|
|
6 |
Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 – a Prospective Cohort Trial
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 81, 2021, Nr. 09: 1047-1054
|
|
|
|
7 |
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective
Enthalten in Archives of gynecology and obstetrics 24.9.2021: 1-9
|
|
|
|
8 |
Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
Enthalten in Archives of gynecology and obstetrics 14.6.2021: 1-9
|
|
|
|
9 |
PARP inhibitors in the treatment of ovarian cancer
Enthalten in Magazine of European Medical Oncology 13.3.2020: 1-4
|
|
|
10 |
17. Österreichischer Kongress "Krebs bei der Frau"
Österreichische Gesellschaft für Gynäkologie und Geburtshilfe. Arbeitsgemeinschaft für Gynäkologische Onkologie. Wissenschaftliche Tagung (28. : 2019 : Salzburg). - Wien, Austria : Springer-Verlag GmbH, AT, [2019]
|
|
Administration
